Order Article Reprints

Mayr L, Guntner AS, Madlener S, Schmook MT, Peyrl A, Azizi AA, Dieckmann K, Reisinger D, Stepien NM, Schramm K, et al. Cerebrospinal Fluid Penetration and Combination Therapy of Entrectinib for Disseminated ROS1/NTRK-Fusion Positive Pediatric High-Grade Glioma. Journal of Personalized Medicine. 2020; 10(4):290. https://doi.org/10.3390/jpm10040290

Mayr, Lisa, Armin S. Guntner, Sibylle Madlener, Maria T. Schmook, Andreas Peyrl, Amedeo A. Azizi, Karin Dieckmann, Dominik Reisinger, Natalia M. Stepien, Kathrin Schramm, and et al. 2020. "Cerebrospinal Fluid Penetration and Combination Therapy of Entrectinib for Disseminated ROS1/NTRK-Fusion Positive Pediatric High-Grade Glioma" Journal of Personalized Medicine 10, no. 4: 290. https://doi.org/10.3390/jpm10040290

Mayr, L., Guntner, A. S., Madlener, S., Schmook, M. T., Peyrl, A., Azizi, A. A., Dieckmann, K., Reisinger, D., Stepien, N. M., Schramm, K., Laemmerer, A., Jones, D. T. W., Ecker, J., Sahm, F., Milde, T., Pajtler, K. W., Blattner-Johnson, M., Strbac, M., Dorfer, C., ... Gojo, J. (2020). Cerebrospinal Fluid Penetration and Combination Therapy of Entrectinib for Disseminated ROS1/NTRK-Fusion Positive Pediatric High-Grade Glioma. Journal of Personalized Medicine, 10(4), 290. https://doi.org/10.3390/jpm10040290